Medtronic

After a five-year pilot, only one company has successfully taken a test through parallel review, but there is growing industry interest.

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

Title: Methods for Diagnosing Prostate Cancer using microRNAs
Patent Number: 8,557,520
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

NEW YORK (GenomeWeb News) – In a sort of test case for personalized medicine, a team of clinicians and researchers used whole-genome sequencing to uncover variants possibly linked to a patient's obsessive-compulsive disorder.

Response Genetics, Taiho Extend MDx Services Pact
Response Genetics could receive up to $950,000 for molecular diagnostic testing services provided to Taiho Pharmaceutical related to the development of cancer treatments.

Dutch gene therapy firm UniQure and academic collaborators have been awarded a three-year grant worth €2.5 million ($3.2 million) from the European Commission to develop a treatment for Huntington’s disease that combines RNAi and gene replacement.

Title: Expression System
Patent Number: 8,415,148
Filed: Aug. 2, 2011
Inventor: Jacques Perrault, San Diego State University

Title: Method for Diagnosing Acute Lymphomic Leukemia using miR-222
Patent Number: 8,349,560
Filed: Oct. 17, 2011
Inventor: Carlo Croce, Ohio State University

Title: miRNA Triplex Formations for the Down-Regulation of Viral Replication
Patent Number: 8,323,891
Filed: July 30, 2009
Inventor: Omar Bagasra, Claflin University

Title: shRNA Molecules and Methods of Use
Patent Number: 8,252,526
Filed: Nov. 9, 2007
Lead Inventor: Donald Rao, Gradalis

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

In Science this week: reduction in bee phylogenetic diversity, and more.